O	0	7	Hypoxic	Hypoxic	JJ	B-NP
O	8	17	induction	induction	NN	I-NP
O	18	20	of	of	IN	B-PP
O	21	24	HIF	HIF	NN	B-NP
O	24	25	-	-	HYPH	B-NP
O	25	31	1alpha	1alpha	NN	I-NP
O	32	35	and	and	CC	I-NP
O	36	40	VEGF	VEGF	NN	I-NP
O	41	51	expression	expression	NN	I-NP
O	52	54	in	in	IN	B-PP
B-Cell	55	59	head	head	NN	B-NP
I-Cell	60	63	and	and	CC	O
I-Cell	64	68	neck	neck	NN	B-NP
I-Cell	69	77	squamous	squamous	JJ	I-NP
I-Cell	78	82	cell	cell	NN	I-NP
I-Cell	83	92	carcinoma	carcinoma	NN	I-NP
I-Cell	93	98	lines	line	NNS	I-NP
O	99	101	is	be	VBZ	B-VP
O	102	110	mediated	mediate	VBN	I-VP
O	111	113	by	by	IN	B-PP
O	114	120	stress	stress	NN	B-NP
O	121	130	activated	activated	JJ	I-NP
O	131	138	protein	protein	NN	I-NP
O	139	146	kinases	kinase	NNS	I-NP
O	146	147	.	.	.	O

B-Cancer	148	153	Solid	Solid	JJ	B-NP
I-Cancer	154	160	tumors	tumor	NNS	I-NP
O	161	165	must	must	MD	B-VP
O	166	175	establish	establish	VB	I-VP
O	176	177	a	a	DT	B-NP
B-Organism_substance	178	183	blood	blood	NN	I-NP
O	184	190	supply	supply	NN	I-NP
O	191	193	in	in	IN	B-SBAR
O	194	199	order	order	NN	O
O	200	202	to	to	TO	B-VP
O	203	214	proliferate	proliferate	VB	I-VP
O	215	218	and	and	CC	I-VP
O	219	223	grow	grow	VB	I-VP
O	223	224	.	.	.	O

B-Cell	225	231	Cancer	Cancer	NN	B-NP
I-Cell	232	237	cells	cell	NNS	I-NP
O	238	245	secrete	secrete	VBP	B-VP
O	246	253	soluble	soluble	JJ	B-NP
O	254	261	factors	factor	NNS	I-NP
O	262	267	which	which	WDT	B-NP
O	268	271	can	can	MD	B-VP
O	272	278	induce	induce	VB	I-VP
O	279	292	proliferation	proliferation	NN	B-NP
O	293	296	and	and	CC	I-NP
O	297	306	migration	migration	NN	I-NP
O	307	309	of	of	IN	B-PP
B-Cell	310	319	capillary	capillary	JJ	B-NP
I-Cell	320	331	endothelial	endothelial	JJ	I-NP
I-Cell	332	337	cells	cell	NNS	I-NP
O	337	338	.	.	.	O

O	339	344	Among	Among	IN	B-PP
O	345	348	the	the	DT	B-NP
O	349	353	most	most	RBS	I-NP
O	354	360	potent	potent	JJ	I-NP
O	361	363	of	of	IN	B-PP
O	364	367	the	the	DT	B-NP
O	368	378	angiogenic	angiogenic	JJ	I-NP
O	379	386	factors	factor	NNS	I-NP
O	387	389	is	be	VBZ	B-VP
O	390	398	vascular	vascular	JJ	B-NP
O	399	410	endothelial	endothelial	JJ	I-NP
O	411	417	growth	growth	NN	I-NP
O	418	424	factor	factor	NN	I-NP
O	425	426	(	(	(	O
O	426	430	VEGF	VEGF	NN	B-NP
O	430	431	)	)	)	O
O	431	432	.	.	.	O

O	433	442	Increased	Increase	VBN	B-NP
O	443	447	VEGF	VEGF	NN	I-NP
O	448	458	expression	expression	NN	I-NP
O	459	461	by	by	IN	B-PP
B-Cancer	462	471	malignant	malignant	JJ	B-NP
I-Cancer	472	478	tumors	tumor	NNS	I-NP
O	479	482	has	have	VBZ	B-VP
O	483	487	been	be	VBN	I-VP
O	488	498	associated	associate	VBN	I-VP
O	499	503	with	with	IN	B-PP
O	504	508	high	high	JJ	B-NP
O	509	520	vascularity	vascularity	NN	I-NP
O	520	521	,	,	,	O
O	522	531	increased	increase	VBD	B-VP
B-Cell	532	538	cancer	cancer	NN	B-NP
I-Cell	539	543	cell	cell	NN	I-NP
O	544	550	growth	growth	NN	I-NP
O	550	551	,	,	,	O
O	552	555	and	and	CC	O
B-Multi-tissue_structure	556	561	lymph	lymph	NN	B-NP
I-Multi-tissue_structure	562	566	node	node	NN	I-NP
O	567	577	metastasis	metastasis	NN	I-NP
O	577	578	.	.	.	O

O	579	586	Reduced	Reduce	VBN	B-NP
O	587	593	oxygen	oxygen	NN	I-NP
O	594	601	tension	tension	NN	I-NP
O	602	605	has	have	VBZ	B-VP
O	606	610	been	be	VBN	I-VP
O	611	616	shown	show	VBN	I-VP
O	617	619	to	to	TO	I-VP
O	620	628	increase	increase	VB	I-VP
O	629	633	VEGF	VEGF	NN	B-NP
O	634	644	production	production	NN	I-NP
O	645	647	by	by	IN	B-PP
O	648	657	induction	induction	NN	B-NP
O	658	660	of	of	IN	B-PP
O	661	664	the	the	DT	B-NP
O	665	678	transcription	transcription	NN	I-NP
O	679	685	factor	factor	NN	I-NP
O	686	693	hypoxia	hypoxia	NN	I-NP
O	694	703	inducible	inducible	JJ	I-NP
O	704	710	factor	factor	NN	I-NP
O	711	712	1	1	CD	I-NP
O	713	718	alpha	alpha	NN	I-NP
O	719	720	(	(	(	O
O	720	723	HIF	HIF	NN	B-NP
O	723	724	-	-	HYPH	B-NP
O	724	730	1alpha	1alpha	NN	I-NP
O	730	731	)	)	)	O
O	731	732	.	.	.	O

O	733	736	The	The	DT	B-NP
O	737	747	mechanisms	mechanism	NNS	I-NP
O	748	750	by	by	IN	B-PP
O	751	756	which	which	WDT	B-NP
O	757	764	hypoxic	hypoxic	JJ	B-NP
B-Cancer	765	770	tumor	tumor	NN	I-NP
O	771	783	environments	environment	NNS	I-NP
O	784	790	induce	induce	VBP	B-VP
O	791	794	HIF	HIF	NN	B-NP
O	794	795	-	-	HYPH	B-NP
O	795	801	1alpha	1alpha	NN	I-NP
O	802	805	and	and	CC	O
O	806	810	VEGF	VEGF	NN	B-NP
O	811	821	expression	expression	NN	I-NP
O	822	825	are	be	VBP	B-VP
O	826	833	largely	largely	RB	B-ADJP
O	834	841	unknown	unknown	JJ	I-ADJP
O	841	842	.	.	.	O

O	843	846	Jun	Jun	NN	B-NP
O	847	848	N	N	NN	I-NP
O	849	857	terminal	terminal	JJ	I-NP
O	858	864	kinase	kinase	NN	I-NP
O	865	866	(	(	(	O
O	866	870	JNK1	JNK1	NN	B-NP
O	870	871	)	)	)	O
O	872	875	and	and	CC	O
O	876	879	p38	p38	NN	B-NP
O	880	886	kinase	kinase	NN	I-NP
O	887	890	are	be	VBP	B-VP
O	891	900	activated	activate	VBN	I-VP
O	901	903	by	by	IN	B-PP
O	904	905	a	a	DT	B-NP
O	906	913	variety	variety	NN	I-NP
O	914	916	of	of	IN	B-PP
O	917	923	stress	stress	NN	B-NP
O	924	931	stimuli	stimulus	NNS	I-NP
O	931	932	.	.	.	O

O	933	935	To	To	TO	B-VP
O	936	945	determine	determine	VB	I-VP
O	946	948	if	if	IN	B-SBAR
O	949	956	hypoxic	hypoxic	JJ	B-NP
O	957	967	activation	activation	NN	I-NP
O	968	970	of	of	IN	B-PP
O	971	976	these	these	DT	B-NP
O	977	983	stress	stress	NN	I-NP
O	984	993	activated	activated	JJ	I-NP
O	994	1001	protein	protein	NN	I-NP
O	1002	1009	kinases	kinase	NNS	I-NP
O	1010	1019	regulated	regulate	VBD	B-VP
O	1020	1023	HIF	HIF	NN	B-NP
O	1023	1024	-	-	HYPH	B-NP
O	1024	1030	1alpha	1alpha	NN	I-NP
O	1031	1034	and	and	CC	I-NP
O	1035	1039	VEGF	VEGF	NN	I-NP
O	1040	1050	expression	expression	NN	I-NP
O	1050	1051	,	,	,	O
O	1052	1054	we	we	PRP	B-NP
O	1055	1062	assayed	assay	VBD	B-VP
O	1063	1067	JNK1	JNK1	NN	B-NP
O	1068	1071	and	and	CC	I-NP
O	1072	1075	p38	p38	NN	I-NP
O	1076	1084	activity	activity	NN	I-NP
O	1085	1087	in	in	IN	B-PP
B-Cell	1088	1096	squamous	squamous	JJ	B-NP
I-Cell	1097	1101	cell	cell	NN	I-NP
I-Cell	1102	1111	carcinoma	carcinoma	NN	I-NP
I-Cell	1112	1113	(	(	(	O
I-Cell	1113	1116	SCC	SCC	NN	B-NP
I-Cell	1116	1117	)	)	)	O
I-Cell	1118	1123	lines	line	NNS	B-NP
O	1124	1129	grown	grow	VBN	B-VP
O	1130	1135	under	under	IN	B-PP
O	1136	1144	normoxic	normoxic	JJ	B-NP
O	1145	1147	or	or	CC	I-NP
O	1148	1155	hypoxic	hypoxic	JJ	I-NP
O	1156	1166	conditions	condition	NNS	I-NP
O	1166	1167	.	.	.	O

O	1168	1175	Hypoxia	Hypoxia	NN	B-NP
O	1176	1183	rapidly	rapidly	RB	B-ADVP
O	1184	1191	induced	induce	VBD	B-VP
O	1192	1196	both	both	CC	O
O	1197	1201	JNK1	JNK1	NN	B-NP
O	1202	1205	and	and	CC	O
O	1206	1209	p38	p38	NN	B-NP
O	1210	1218	activity	activity	NN	I-NP
O	1219	1221	in	in	IN	B-PP
O	1222	1227	these	these	DT	B-NP
B-Cell	1228	1233	cells	cell	NNS	I-NP
O	1233	1234	.	.	.	O

O	1235	1239	This	This	DT	B-NP
O	1240	1250	activation	activation	NN	I-NP
O	1251	1261	correlated	correlate	VBD	B-VP
O	1262	1266	with	with	IN	B-PP
O	1267	1276	induction	induction	NN	B-NP
O	1277	1279	of	of	IN	B-PP
O	1280	1283	HIF	HIF	NN	B-NP
O	1283	1284	-	-	HYPH	B-NP
O	1284	1290	1alpha	1alpha	NN	I-NP
O	1291	1301	expression	expression	NN	I-NP
O	1302	1305	and	and	CC	O
O	1306	1309	DNA	DNA	NN	B-NP
O	1310	1317	binding	binding	NN	I-NP
O	1318	1326	activity	activity	NN	I-NP
O	1327	1332	which	which	WDT	B-NP
O	1333	1336	was	be	VBD	B-VP
O	1337	1344	blocked	block	VBN	I-VP
O	1345	1347	by	by	IN	B-PP
O	1348	1351	the	the	DT	B-NP
O	1352	1355	p38	p38	NN	I-NP
O	1356	1365	inhibitor	inhibitor	NN	I-NP
O	1366	1374	SB203580	SB203580	NN	I-NP
O	1374	1375	.	.	.	O

O	1376	1383	Hypoxia	Hypoxia	NN	B-NP
O	1384	1388	also	also	RB	B-ADVP
O	1389	1398	increased	increase	VBD	B-VP
O	1399	1403	VEGF	VEGF	NN	B-NP
O	1404	1414	production	production	NN	I-NP
O	1415	1417	by	by	IN	B-PP
B-Cell	1418	1421	SCC	SCC	NN	B-NP
I-Cell	1422	1427	lines	line	NNS	I-NP
O	1427	1428	,	,	,	O
O	1429	1434	which	which	WDT	B-NP
O	1435	1438	was	be	VBD	B-VP
O	1439	1448	inhibited	inhibit	VBN	I-VP
O	1449	1451	by	by	IN	B-PP
O	1452	1461	treatment	treatment	NN	B-NP
O	1462	1466	with	with	IN	B-PP
O	1467	1475	SB203580	SB203580	NN	B-NP
O	1475	1476	.	.	.	O

O	1477	1491	Overexpression	Overexpression	NN	B-NP
O	1492	1494	of	of	IN	B-PP
O	1495	1499	JNK1	JNK1	NN	B-NP
O	1500	1502	or	or	CC	I-NP
O	1503	1506	p38	p38	NN	I-NP
O	1507	1510	was	be	VBD	B-VP
O	1511	1521	sufficient	sufficient	JJ	B-ADJP
O	1522	1524	to	to	TO	B-VP
O	1525	1531	induce	induce	VB	I-VP
O	1532	1535	HIF	HIF	NN	B-NP
O	1535	1536	-	-	HYPH	B-NP
O	1536	1542	1alpha	1alpha	NN	I-NP
O	1543	1546	and	and	CC	O
O	1547	1551	VEGF	VEGF	NN	B-NP
O	1552	1562	expression	expression	NN	I-NP
O	1562	1563	.	.	.	O

O	1564	1569	These	These	DT	B-NP
O	1570	1577	results	result	NNS	I-NP
O	1578	1586	indicate	indicate	VBP	B-VP
O	1587	1591	that	that	IN	B-SBAR
O	1592	1601	induction	induction	NN	B-NP
O	1602	1604	of	of	IN	B-PP
O	1605	1610	SAPKs	SAPK	NNS	B-NP
O	1611	1613	by	by	IN	B-PP
O	1614	1621	hypoxia	hypoxia	NN	B-NP
O	1622	1631	regulates	regulate	VBZ	B-VP
O	1632	1635	HIF	HIF	NN	B-NP
O	1635	1636	-	-	HYPH	I-NP
O	1636	1642	1alpha	1alpha	NN	I-NP
O	1643	1646	and	and	CC	I-NP
O	1647	1651	VEGF	VEGF	NN	I-NP
O	1652	1662	expression	expression	NN	I-NP
O	1663	1665	in	in	IN	B-PP
B-Cell	1666	1670	head	head	NN	B-NP
I-Cell	1671	1674	and	and	CC	I-NP
I-Cell	1675	1679	neck	neck	NN	I-NP
I-Cell	1680	1689	carcinoma	carcinoma	NN	I-NP
I-Cell	1690	1694	cell	cell	NN	I-NP
I-Cell	1695	1700	lines	line	NNS	I-NP
O	1700	1701	.	.	.	O

